Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Strachan

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Placenta|September 14, 2000
In utero perfusing fraction maps in normal and growth restricted pregnancy measured using IVIM echo-planar MRIR J Moore, B K Strachan, D J Tyler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumorsS Goel, R J Bauer, K Desai, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Placenta|September 14, 2000
In utero perfusing fraction maps in normal and growth restricted pregnancy measured using IVIM echo-planar MRIR J Moore, B K Strachan, D J Tyler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumorsS Goel, R J Bauer, K Desai, et al.
Pageof 2